Subhashis Banerjee, MD

Bristol Myers Squibb
Princeton, NJ, United States

Vice President & Disease Area Head, Rheumatology and Dermatology at Bristol Myers Squibb,

Disclosure information not submitted.

Presentation(s):

• 576: CH Vasculitis: Cryoglobulinemic Vasculitis: An Update and Small-Vessel Vasculitis Abstract Lightening Review

  Sunday, November 13, 2022
  1:00 PM – 2:00 PM Eastern Time

• 2134: Deucravacitinib Long-term Efficacy and Safety in Plaque Psoriasis: 2-Year Results from the Phase 3 POETYK PSO Program

  Monday, November 14, 2022
  1:00 PM – 3:00 PM Eastern Time